Noninvasive blood test which delivers high quality circulating tumor cell (CTC) enrichment and circulating tumor DNA (ctDNA) using the advantages of the Liquid Biopsy and Next Generation Sequencing (NGS). The ability to detect and quantify tumor mutations has proven effective in tracking tumor dynamics in real time.


Spiral as a non-invasive test allows to decipher the genetic tumor fingerprint in asymptomatic people at risk and under medical prescription. Spiral is a personalized blood test which delivers the number of circulating tumor cells in the sample and analysed more than 3500 mutations associated to cancer, including hereditary cancer genes if it is needed.